📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A. (2018)

First Author: Cheung SY

Attributed to: Maximising patient benefit: Leeds’ Interdisciplinary approach to translation (CiC 2017) funded by UKRI

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.25659

PubMed Identifier: 30038709

Publication URI: http://europepmc.org/abstract/MED/30038709

Type: Journal Article/Review

Volume: 9

Parent Publication: Oncotarget

Issue: 51

ISSN: 1949-2553